Eosinophil CD48 interactions with Candida albicans Als6 is protective in vitro and in mouse systemic candidiasis

Ilan Zaffran1, Pratibha Gaur1, Prince Ofori1

  • 1Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Nature Communications
|October 21, 2025
PubMed

Insights

Eosinophils protect against Candida albicans infections by releasing mediators that inhibit fungal growth. This study reveals the CD48/Als6 interaction is crucial for eosinophil-mediated defense.

Area of Science:

  • Immunology
  • Mycology
  • Infectious Diseases

Background:

  • Eosinophils are key innate immune cells involved in allergies and parasitic infections.
  • Their function in fungal infections, particularly systemic candidiasis, remains poorly understood.
  • Candida albicans is a common fungal pathogen causing opportunistic infections.

Purpose of the Study:

  • To investigate the role of eosinophils in systemic Candida albicans infections.
  • To identify host-pathogen interactions mediating eosinophil responses to C. albicans.
  • To determine the protective capacity of eosinophils in a murine model of candidiasis.

Main Methods:

  • In vitro assays using human eosinophils and C. albicans.
  • Genetic depletion (Δdbl/GATA) and antibody-mediated depletion (anti-IL-5) of eosinophils in mice.
  • Assessment of fungal burden, survival rates, and host-pathogen interactions (CD48/Als6).

Main Results:

  • Eosinophils phagocytose C. albicans, but hyphae release candidalysin, causing eosinophil death.
  • Eosinophil mediators, like major basic protein 1 (MBP-1), inhibit C. albicans growth.
  • Eosinophil-deficient mice showed increased fungal burden and reduced survival.
  • CD48 was identified as a key eosinophil receptor for C. albicans via Als6.

Conclusions:

  • Eosinophils play a protective role in systemic C. albicans infections.
  • The CD48/Als6 interaction is a critical axis for eosinophil-mediated immunity against C. albicans.
  • Targeting this axis could offer therapeutic strategies for invasive fungal infections.